Involvement of AP-1 in interleukin-1α-stimulated MMP-3 expression in human trabecular meshwork cells

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 8, 2003, Pages 3494-3501

  Fleenor, Debra L ^b   Pang, Iok Hou ^a   Clark, Abbot F ^b  

^a ALCON RESEARCH LTD   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; PROSTAGLANDIN SYNTHASE; PROTEIN INHIBITOR; PROTEIN KINASE C; SPHINGOMYELIN PHOSPHODIESTERASE; SR 11302; STROMELYSIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 1 INHIBITOR; UNCLASSIFIED DRUG;

AQUEOUS HUMOR OUTFLOW; ARTICLE; CILIARY MUSCLE; CLINICAL PATHWAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GLAUCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; ZYMOGRAPHY;

ADOLESCENT; AGED; AGED, 80 AND OVER; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INTERLEUKIN-1; MAP KINASE KINASE KINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; TRABECULAR MESHWORK; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0042366186     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0757     Document Type: Article

References (41)

1. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
2. Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993; 34:3386-3395.
3. Parshley DE, Bradley JM, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795-804.
4. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res. 1998;17:276-285.
5. Pang I-H, Hellberg PE, Fleenor DL, Jacobson N, Clark AF. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-3493.
6. Ando H, Twining SS, Yue BY, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci. 1993; 34:3541-3548.
7. Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
8. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.
9. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996:15:869-875.
10. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol. 1997; 41(suppl 2):S53-S59.
11. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2214-2223.
12. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997; 38:2772-2780.
13. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr. 1997;7:159-178.
14. Clark AF. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci. 1998;39:2514-2516.
15. Kee C, Seo K. The effect of interleukin-1alpha on outflow facility in rat eyes. J Glaucoma. 1997;6:246-249.
16. Dawson MM. Interleukin-1. In Lymphokines and Interleukins. Boca Raton, FL: CRC Press; 1991:83-105.
17. Dunn CJ. Cytokines as mediators of chronic inflammatory diseases. In Kimball ES, ed. Cytokines and Inflammation. Boca Raton, FL: CRC Press; 1991:1-33.
18. Bursten SL, Harris WE. Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells. Am J Physiol. 1994;266:C1093-C1104.
19. Kuno K, Matsushima K. The IL-1 receptor signaling pathway. J Leukoc Biol. 1994;56:542-547.
20. Bankers Fulbright JL, Kalli KR, McKean DJ. Interleukin-1 signal transduction. Life Sci. 1996;59:61-83.
21. Welsh N. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH sub(2)-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem. 1996;271:8307-8312.
22. Eder J. Tumour necrosis factor alpha and interleukin 1 signalling: Do MAPKK kinases connect it all? Trends Pharmacol Sci. 1997; 18:319-322.
23. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-Kappa B induction by TNF, CD95 and IL-1. Nature. 1997;385:540-544.
24. Ridley SH, Sarsfield SJ, Lee JC, et al. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol. 1997;158:3165-3173.
25. Steely HT Jr, English Wright SL, Clark AF. The similarity of protein expression in trabecular meshwork and lamina cribrosa: implications for glaucoma. Exp Eye Res. 2000;70:17-30.
26. Wordinger RJ, Lambert W, Agarwal R, Talati M, Clark AF. Human trabecular meshwork cells secrete neurotrophins and express neurotrophin receptors (Trk). Invest Ophthalmol Vis Sci. 2000;41:3833-3841.
27. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
28. Lambert W, Agarwal R, Howe W, Clark AF, Wordinger RJ. Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 2001;42:2315-2323.
29. Tamm E, Flugel C, Baur A, Lütjen-Drecoll E. Cell cultures of human ciliary muscle: growth, ultrastructural and immunocytochemical characteristics. Exp Eye Res. 1991;53:375-387.
30. Pang IH, Shade DL, Tamm E, DeSantis L. Single-cell contraction assay for human ciliary muscle cells: effect of carbachol. Invest Ophthalmol Vis Sci. 1993;34:1876-1879.
31. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology. 1995;136:4790-4795.
32. Abate A, Schroder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-kappaB. Life Sci. 1998;62:1081-1088.
33. Fanjul A, Dawson MI, Hobbs PD, et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994;372:107-111.
34. Quinones S, Buttice G, Kurkinen M. Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J. 1994;302:471-477.
35. Han Y, Meng T, Murray NR, Fields AP, Brasier AR. Interleukin-1-induced nuclear factor-kappa B-I kappa B alpha autoregulatory feedback loop in hepatocytes: a role for protein kinase C alpha in post-transcriptional regulation of I Kappa B alpha resynthesis. J Biol Chem. 1999;274:939-947.
36. Sirum Connolly K, Brinckerhoff CG. Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1. Nucleic Acids Res. 1991;19:335-341.
37. Hui A, Min WX, Tang J, Cruz TF. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum. 1998;41:869-878.
38. Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappaB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002;21:251-262.
39. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 1997;15:519-526.
40. Alexander JP, Acott TS. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2001;42:2831-2838.
41. Gekeler V, Boer R, Uberall F, et al. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br J Cancer. 1996;74:897-905.